CEACAM5 and pancreatic adenocarcinoma: To validate our CEACAM5 observations, we obtained batch corrected RNA-seq data from The Cancer Genome Atlas Pan-Cancer Initiative for primary and metastatic/recurrent lung adenocarcinoma, breast invasive carcinoma, and pancreatic adenocarcinoma tumors, as well as normal tissues.